Form 4: Globus Medical Director Davidar D. Davidar Executes Stock Option and Sells Shares

Director Davidar D. Davidar exercised stock options and sold 25,000 shares of Globus Medical Inc. (GMED) Class A Common Stock on September 13, 2024.

Summary

• On September 13, 2024, Davidar D. Davidar, a director of Globus Medical Inc. (GMED), exercised stock options to acquire 25,000 shares of Class A Common Stock at a price of $25.52 per share.
• Simultaneously, Davidar sold 25,000 shares of Class A Common Stock at a weighted average price of $70.46, with individual transactions ranging from $70.20 to $70.80.
• Following these transactions, Davidar directly owns 566,275 shares of Class A Common Stock and indirectly owns 205,967 shares through the Davidar Family Irrevocable Trust U/A 8/6/09.
• The shares held in the trust are for the benefit of Davidar's spouse and children, with Davidar's spouse serving as the trustee.

Sentiment

Score: 5

Explanation: This is a neutral disclosure of stock transactions by a company director. It doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, providing transparency into the trading activities of company directors. It's common for executives to exercise stock options and sell shares for personal financial management.

Stakeholder Impact

• The transaction could have a minor impact on shareholders due to the change in ownership, but it's unlikely to be significant given the relatively small number of shares involved compared to the total outstanding shares.
• The transaction has no direct impact on employees, customers, suppliers, or creditors.

Key Dates